No Data
No Data
bluebird bio | 10-Q: Q1 2024 Earnings Report
Express News | Bluebird bio Inc -Restatement Had No Impact on Company's Cash Position or Revenue
Bluebird Bio Announces Completion Of Its Restatement And Filing Of Its 2023 Form 10-K And Q1 2024 Form 10-Q >BLUE
bluebird bio | 10-K: FY2023 Annual Report
California Launches $500 Million Initiative for Zero-Emission School Buses -- OPIS
FDA Will Not Meet Ahead of Bluebird Bio's Sickle Cell Disease Gene Therapy PDUFA Date